George D. Yancopoulos

2018

In 2018, George D. Yancopoulos earned a total compensation of $25.4M as President and Chief Scientific Officer at Regeneron Pharmaceuticals, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,510,598
Option Awards$21,339,913
Salary$1,130,900
Other$399,718
Total$25,381,129

Yancopoulos received $21.3M in option awards, accounting for 84% of the total pay in 2018.

Yancopoulos also received $2.5M in non-equity incentive plan, $1.1M in salary and $399.7K in other compensation.

Rankings

In 2018, George D. Yancopoulos' compensation ranked 86th out of 14,244 executives tracked by ExecPay. In other words, Yancopoulos earned more than 99.4% of executives.

ClassificationRankingPercentile
All
86
out of 14,244
99th
Division
Manufacturing
24
out of 5,758
100th
Major group
Chemicals And Allied Products
9
out of 2,119
100th
Industry group
Drugs
7
out of 1,808
100th
Industry
Pharmaceutical Preparations
4
out of 1,382
100th
Source: SEC filing on April 26, 2019.

Yancopoulos' colleagues

We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2018.

2018

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2018

Marion McCourt

Regeneron Pharmaceuticals

Senior Vice President, Commercial

2018

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2018

Daniel Van Plew

Regeneron Pharmaceuticals

Executive Vice President and General Manager, Industrial Operations and Product Supply

News

In-depth

You may also like